Structural biologists at the University of Cincinnati have made a groundbreaking discovery by visualizing the iRhom1 protein bound to the ADAM17 enzyme, marking a first in the field. This research, conducted by the Seegar Lab and published in Cell Reports, utilized cryogenic electron microscopy to explore the structural dynamics of these proteins. ADAM17 plays a vital role in human tissue development and immune response, making it a key target for drug development aimed at chronic inflammatory diseases. The study identified critical structural elements in both iRhom1 and iRhom2 proteins that facilitate communication across the cell surface, linking intracellular signals to ADAM17 activation. Interestingly, while the structures of iRhom1 and iRhom2 are identical, their functions diverge, suggesting a complex regulatory mechanism. Additionally, researchers investigated a mutation in iRhom1 associated with cardiomyopathy, revealing that it impairs the protein's functionality. These findings not only enhance our understanding of ADAM17's role in various diseases but also pave the way for novel therapeutic strategies.